Biotechnology Assets, S.A. (BME:BST)
Spain · Delayed Price · Currency is EUR 0.2250
0.00 (0.00%)
Sep 17, 2026, 1:27 PM CET
Biotechnology Assets Market Cap
Biotechnology Assets has a market cap or net worth of €16.71 million as of September 16, 2026. Its market cap has decreased by -36.52% in one year.
Market Cap
16.71M
Enterprise Value
17.79M
Revenue
3.43M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.23
ChartMarket Cap Chart
Since May 29, 2018, Biotechnology Assets's market cap has decreased from 74.66M to 16.71M, a decrease of -77.61%. That is a compound annual growth rate of -16.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 16.71M | 17.11% |
| Dec 31, 2025 | 14.27M | -21.93% |
| Dec 31, 2024 | 18.28M | -20.03% |
| Dec 29, 2023 | 22.86M | 84.02% |
| Dec 30, 2022 | 12.42M | -40.67% |
| Dec 30, 2021 | 20.94M | -3.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.75B |
| Laboratorios Farmaceuticos Rovi | 2.96B |
| Almirall | 2.30B |
| Faes Farma | 1.41B |
| Oryzon Genomics | 229.00M |
| Atrys Health | 222.41M |
| Prim, S.A. | 215.15M |
| Laboratorio Reig Jofre | 214.11M |